GPX4 overexpression ameliorated, whereas GPX4 heterodeletion exaggerated myocardial ischemia/reperfusion (I/R) injury and doxorubicin-induced cardiomyopathy in mice (Miyamoto et al., 2022; Tadokoro et al., 2023). Here, GPX4 is linked to cardiomyopathy.